Mice lacking the CCR9 CC-chemokine receptor show a mild impairment of early T- and B-cell development and a reduction in T-cell receptor γδ+ gut intraepithelial.

Slides:



Advertisements
Similar presentations
Volume 6, Issue 1, Pages (January 1997)
Advertisements

Volume 109, Issue 1, Pages (April 2002)
Volume 93, Issue 3, Pages (May 1998)
Role of AP1/NFE2 binding sites in endogenous α-globin gene transcription by Melanie R. Loyd, Yasuhiro Okamoto, Mindy S. Randall, and Paul A. Ney Blood.
Hmgb3: an HMG-box family member expressed in primitive hematopoietic cells that inhibits myeloid and B-cell differentiation by Michael J. Nemeth, David.
Volume 10, Issue 5, Pages (May 1999)
Volume 8, Issue 1, Pages (January 1998)
Volume 18, Issue 5, Pages (May 2003)
Volume 7, Issue 2, Pages (February 2001)
Runx1 deficiency predisposes mice to T-lymphoblastic lymphoma
Volume 9, Issue 4, Pages (October 1998)
Important scaffold function of the Janus kinase 2 uncovered by a novel mouse model harboring a Jak2 activation-loop mutation by Eric Keil, David Finkenstädt,
Growth Disturbance in Fetal Liver Hematopoiesis of Mll-Mutant Mice
Volume 5, Issue 3, Pages (September 1996)
by Hiromi Gunshin, Carolyn N. Starr, Cristina DiRenzo, Mark D
Volume 11, Issue 2, Pages (August 1999)
Volume 11, Issue 5, Pages (November 1999)
Volume 19, Issue 6, Pages (December 2003)
Volume 5, Issue 5, Pages (November 1996)
Redundant and Unique Roles of Two Enhancer Elements in the TCRγ Locus in Gene Regulation and γδ T Cell Development  Na Xiong, Chulho Kang, David H Raulet 
Thorsten Buch, Frédéric Rieux-Laucat, Irmgard Förster, Klaus Rajewsky 
Volume 5, Issue 4, Pages (October 1996)
Volume 16, Issue 6, Pages (June 2002)
The Death Domain Kinase RIP Mediates the TNF-Induced NF-κB Signal
Volume 9, Issue 4, Pages (October 1998)
Volume 10, Issue 5, Pages (November 2002)
Volume 10, Issue 5, Pages (May 1999)
Balthazar B Cazac, Jürgen Roes  Immunity 
Volume 9, Issue 3, Pages (September 1998)
Volume 19, Issue 2, Pages (August 2003)
Requirement for the Thymus in αβ T Lymphocyte Lineage Commitment
In Vivo Ablation of Surface Immunoglobulin on Mature B Cells by Inducible Gene Targeting Results in Rapid Cell Death  Kong-Peng Lam, Ralf Kühn, Klaus.
Volume 10, Issue 5, Pages (May 1999)
CD22 is a negative regulator of B-cell receptor signalling
Pax5/BSAP Maintains the Identity of B Cells in Late B Lymphopoiesis
Ku86-Deficient Mice Exhibit Severe Combined Immunodeficiency and Defective Processing of V(D)J Recombination Intermediates  Chengming Zhu, Molly A Bogue,
Yang Xu, Genhong Cheng, David Baltimore  Immunity 
Genetic disruption of p38α Tyr323 phosphorylation prevents T-cell receptor–mediated p38α activation and impairs interferon-γ production by Ludmila Jirmanova,
Volume 17, Issue 1, Pages (July 2002)
T Cell-Produced Transforming Growth Factor-β1 Controls T Cell Tolerance and Regulates Th1- and Th17-Cell Differentiation  Ming O. Li, Yisong Y. Wan, Richard.
Expression of the 11β-hydroxysteroid dehydrogenase 2 gene in the mouse
Volume 9, Issue 5, Pages (November 1998)
Volume 25, Issue 6, Pages (December 2006)
Volume 14, Issue 5, Pages (May 2001)
Both E12 and E47 Allow Commitment to the B Cell Lineage
Positive Selection of Dendritic Epidermal γδ T Cell Precursors in the Fetal Thymus Determines Expression of Skin-Homing Receptors  Na Xiong, Chuhlo Kang,
Volume 4, Issue 4, Pages (April 1996)
Volume 16, Issue 5, Pages (May 2002)
Ludovica Bruno, Hans Jörg Fehling, Harald von Boehmer  Immunity 
A Prematurely Expressed Igκ Transgene, but Not a VκJκ Gene Segment Targeted into the Igκ Locus, Can Rescue B Cell Development in λ5-Deficient Mice  Roberta.
IgH Class Switch Recombination to IgG1 in DNA-PKcs-Deficient B Cells
Volume 85, Issue 6, Pages (June 1996)
Volume 2, Issue 4, Pages (October 1998)
Targeted disruption of the Nijmegen breakage syndrome gene NBS1 leads to early embryonic lethality in mice  Jie Zhu, Simone Petersen, Lino Tessarollo,
Multiple Developmental Stage–Specific Enhancers Regulate CD8 Expression in Developing Thymocytes and in Thymus-Independent T Cells  Wilfried Ellmeier,
Volume 31, Issue 2, Pages (August 2009)
Joan E Durbin, Renée Hackenmiller, M.Celeste Simon, David E Levy  Cell 
Generation of Siva conditional knockout mice.
Fig. 4. Targeted disruption of STK35 transcripts in mouse.
CD83 Expression Influences CD4+ T Cell Development in the Thymus
Securin is not required for cellular viability, but is required for normal growth of mouse embryonic fibroblasts  Junjie Mei, Xingxu Huang, Pumin Zhang 
Expression of multiple forms of MEL1 gene products.
Volume 10, Issue 8, Pages (April 2000)
The Death Domain Kinase RIP Mediates the TNF-Induced NF-κB Signal
Volume 94, Issue 2, Pages (July 1998)
Volume 14, Issue 1, Pages (January 2001)
David A Schwarz, Carol D Katayama, Stephen M Hedrick  Immunity 
Volume 4, Issue 2, Pages (February 1996)
Analysis of Type 2 Immunity In Vivo with a Bicistronic IL-4 Reporter
Volume 11, Issue 2, Pages (August 1999)
Presentation transcript:

Mice lacking the CCR9 CC-chemokine receptor show a mild impairment of early T- and B-cell development and a reduction in T-cell receptor γδ+ gut intraepithelial lymphocytes by Marc-André Wurbel, Marie Malissen, Delphine Guy-Grand, Eric Meffre, Michel C. Nussenzweig, Mireille Richelme, Alice Carrier, and Bernard Malissen Blood Volume 98(9):2626-2632 November 1, 2001 ©2001 by American Society of Hematology

Generation and identification of CCR9-deficient mice. Generation and identification of CCR9-deficient mice. (A) Partial restriction map of the wild-type CCR9 gene (i). ░, exons 2 and 3. The restriction sites are RI, EcoRI, and H,HindIII. Targeting vector used for the deletion of exon 3 (ii). Two diagnostic HindIII and EcoRI restriction sites were introduced at each end of the loxP-flanked neomycin resistance gene (neo). Open boxes correspond to the thymidine kinase expression cassette (tk), to the loxP-flanked neomycin gene, and to the pBluescript IIKS+ vector (pBS). Structure of the targeted allele following homologous recombination (iii). Final structure of the targeted allele after removal of the neomycin resistance gene via cre-mediated recombination (iv). The 5′ and 3′ single-copy probes used to verify the targeting events are indicated as ▪, and the position of the primers used to monitor the germline transmission of the intented mutation is indicated by arrows. (B) Southern blot analysis of the recombinant ES cell clone VC9 that gave germline transmission prior to deletion of the neomycin resistance gene. DNA was digested withEcoRI and hybridized with the 3′ single-copy probe. (C) DNA-PCR analysis of wild-type (+/+), neomycin-deleted heterozygous (+/−), and neomycin-nondeleted heterozygous (+/neo) littermates using the pair of primers shown in (A). After deletion of the neomycin resistance gene, the targeted CCR9 allele gave an amplified PCR product of 330 bp. Amplified products were run on an agarose gel and stained with ethidium bromide. Marc-André Wurbel et al. Blood 2001;98:2626-2632 ©2001 by American Society of Hematology

Analysis of the chemokine receptor transcripts expressed in freshly isolated thymocytes. Analysis of the chemokine receptor transcripts expressed in freshly isolated thymocytes. Total RNA extracted from thymi and spleen from CCR9-deficient and wild-type mice were analyzed by multiprobe ribonuclease protection assay using a mCR-5 RiboQuant mouse template set (BD Pharmingen). The autoradiogram shows the mCR-5–probe set not treated with RNases (lane 1), and the RNase-protected bands following hybridization with control yeast tRNA (line 2) with RNA isolated from CCR9-deficient (lane 3), or wild-type thymi (lane 4). Also shown are the RNase-protected bands obtained after hybridization with RNA isolated from CCR9-deficient spleens (lane 5), or wild-type spleens (lane 6). The identity of the various protected bands is indicated on the left. Marc-André Wurbel et al. Blood 2001;98:2626-2632 ©2001 by American Society of Hematology

T-cell development in CCR9-deficient mice. T-cell development in CCR9-deficient mice. Thymocytes from wild-type and CCR9-deficient (CCR9−/−) mice were analyzed by 3-color flow cytometry for the expression of CD4, CD8, and CD3. The percentage of cells found in each quadrant is indicated, and the percentage of CD3high, and of CD3high plus CD3intermediate thymocytes indicated for the single-color histograms is shown in the lower panel. Marc-André Wurbel et al. Blood 2001;98:2626-2632 ©2001 by American Society of Hematology

Chemotactic responses to TECK/CCL25. Chemotactic responses to TECK/CCL25. Freshly isolated thymocytes from CCR9-deficient (CCR9−/−), CCR9-heterozygous (CCR9+/−) and wild-type mice were placed in the upper chamber of a 24-well Transwell plate. Recombinant TECK/CCL25 (200 nM) or culture medium, as a negative control, were placed in the lower chamber. After 4 hours of incubation, cells in the lower chamber were counted both manually and by flow cytometry. Marc-André Wurbel et al. Blood 2001;98:2626-2632 ©2001 by American Society of Hematology

Fetal thymic ontogeny in CCR9-deficient mice. Fetal thymic ontogeny in CCR9-deficient mice. (A) The number of lymphoid cells found in CCR9-deficient (□) and wild-type (■) thymi are represented at different ages of embryonic life. (B) CD4/CD8 staining profiles on total thymocytes from wild-type and from CCR9-deficient mice at different ages of embryonic life. The percentage of cells within each quadrant is indicated in the lower-right panel. Marc-André Wurbel et al. Blood 2001;98:2626-2632 ©2001 by American Society of Hematology

Peripheral TCRαβ and TCRγδ cells in CCR9-deficient mice. Peripheral TCRαβ and TCRγδ cells in CCR9-deficient mice. Lymphocytes isolated from lymph nodes and spleens of CCR9-deficient and wild-type mice were analyzed by 4-color flow cytometry. Two-color plots represent the TCRαβ versus TCRγδ staining observed on CD3-positive cells. The percentages of TCRαβ and TCRγδ cells found in each organ are indicated. Marc-André Wurbel et al. Blood 2001;98:2626-2632 ©2001 by American Society of Hematology

B-cell development in CCR9-deficient mice. B-cell development in CCR9-deficient mice. (A) Two-color plots show the CD4/B220 and HSA/CD43 profiles found on B220-enriched bone marrow B cells from CCR9-deficient, CCR9-heterozygous, and wild-type mice. Also shown is the percentage of CD4+B220+ and CD43+HAS− B cells. (B) Two-color plots show the CD43/CD25 profile of B220-enriched bone marrow B cells from CCR9-deficient, CCR9-heterozygous, and wild-type mice. Numbers indicate the percentage of cells within this quadrant. Marc-André Wurbel et al. Blood 2001;98:2626-2632 ©2001 by American Society of Hematology

Gut IELs in CCR9-deficient mice. Gut IELs in CCR9-deficient mice. (A) Analysis of tissue sections allowed us to determine the number of total IELs and to normalize the number to 100 epithelial cells.29 (B) Comparison of the various CD3+IEL subsets found in CCR9-deficient and in wild-type mice. IELs were labeled with the specified combination of antibodies and analyzed by flow cytometry. (C) IELs from CCR9-deficient or wild-type mice were analyzed by 2-color flow cytometry for the expression of TCRδ versus CD3. The percentage of TCRγδ+ cells is indicated. Marc-André Wurbel et al. Blood 2001;98:2626-2632 ©2001 by American Society of Hematology